Authors

In Mississippi’s Maternal Health Crisis, Pharmacies Become Lifelines

The Medications Optimizing Maternal Safety (MOMS) program offers vital support to pregnant patients through community pharmacies.

Biosimilars: A Guide for Pharmacists

Given the growing market availability and current underutilization of biosimilars, pharmacists must possess a comprehensive understanding of these agents to effectively advocate for their adoption.

McKesson ideaShare 2025: Micro-Access Pharmacies Expand Care Through Innovation, Technology, and Policy

Pharmacy Logistics, Emerging Safety and Efficacy Data, and Future Directions for Menin Inhibitors in Acute Leukemias

Targeted menin inhibitors offer new hope for patients with difficult-to-treat acute leukemias.

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.

Navigating Prescription Stimulant Use: Safety, Legal, and Supply Challenges in Pharmacy Practice

The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.

Cardiology Pharmacists Redefine Their Role in a Rapidly Evolving Cardiovascular Landscape

Experts discuss practice expansion, guideline updates, and team-based care.

The Next Generation Pharmacy Operating System Must Be Designed for Health Systems

A unified specialty pharmacy platform replaces fragmented tools, streamlines access, boosts reimbursement clarity, and supports advanced therapies.

Comprehensive Care and Innovation: The Future of Cardiovascular Pharmacy

Emerging therapies, AI, and patient-centered approaches are reshaping cardiovascular pharmacy.

Risks and Impacts of Cannabis Use During Pregnancy: A Growing Concern for Neonatal Health

Cannabis use during pregnancy may harm fetal development and long-term health.

Cardiovascular Risks of BTK Inhibitors: What Pharmacists Need to Know

Sarah Spinler, PharmD, FCCP, FAHA, FASHP, AACC, discussed management of atrial fibrillation in patients with cancer.

Optimizing Health System Pharmacies: Leveraging Data, Performance Indicators, and Automation

Health system pharmacies can enhance operational and financial performance by leveraging key performance indicators, data-driven tools, and automation, ultimately supporting the broader health system’s adaptability and growth within an evolving health care landscape.

From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes

Explore the rising prevalence of diabetes in the US, its various types, and the critical role pharmacists play in patient care.

Medetomidine in the Illicit Drug Supply: What Pharmacists Need to Know About "Rhino Tranq" and Naloxone-Resistant Overdoses

As medetomidine rapidly displaces xylazine as a fentanyl adulterant, pharmacists must recognize its distinct toxidrome, understand why naloxone alone is insufficient, and support updated harm reduction strategies in an increasingly complex overdose landscape.

What Real-World Data Show About Moving Patients From Humira to Biosimilars

Data show adalimumab biosimilars can replace brand-name treatment with minimal gaps, high persistence, and sharply lower drug costs for patients and plans.

The Expanding Role of CDK 4/6 Inhibitors in Breast Cancer Treatment

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.

Neuriva: A Closer Look at the Efficacy and Safety of this Popular Supplement

Managing Sickle Cell Disease: Modern Pain Strategies and Pharmacologic Advances

Effective SCD pain management requires an integrated, multimodal strategy across outpatient and inpatient settings.

The Evolving Landscape of Polycythemia Vera Treatment

Current treatment strategies are aimed at reducing hematocrit and symptom burden through phlebotomy, aspirin, and cytoreductive agents, while emerging therapies offer promise for better disease control and quality of life.

Outcomes of Older Patients on Enfortumab Vedotin for Urothelial Carcinoma

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

A Practical Guide to Peer Review in Pharmacy Practice

A review offering guidance to pharmacists on the importance of peer review as well as a tutorial on how to perform and respond to peer review.

GLP-1s Were Only the Beginning: The Growing Role of Pharmacists in Peptide Medicine

Clinical pharmacists may play an increasingly important role in longitudinal metabolic care, medication optimization, patient education, and multidisciplinary peptide management.

Why SSRI Tapering Gets Harder at Lower Doses: The Role of Serotonin Transporter Occupancy

Serotonin transporter occupancy explains sertraline withdrawal symptoms and helps distinguish relapse.

NCPA: Independent Pharmacies Facing Cash Flow Gaps Under Medicare Drug Price Negotiation Program

Ronna Hauser breaks down findings showing that delayed manufacturer refunds under the Medicare Drug Price Negotiation Program are forcing retail pharmacies to minimize high-dollar drug inventory and dip into savings to stay afloat.

Translation: A Pharmacist’s Greatest Skill

Modern pharmacists increasingly serve as translators, helping patients navigate health care complexity, reduce confusion, and improve understanding through meaningful conversations.

FGFR Inhibitors for Treatment of Primary CNS Tumors

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

A Pharmacist’s Guide to Blockbuster Patent Expirations: 2025 and Beyond

This shift brings new responsibilities and opportunities, from managing inventory changes to counseling patients on alternative therapies.

Topiramate’s Emerging Role in Cocaine Use Disorder

Topiramate, an antiseizure medication, has an off-label indication for cocaine use disorder and it received a conditional recommendation with a low certainty of evidence.

Localized Treatments for High-Risk NMIBC: What’s New, What Holds, and What’s Coming

Emerging therapeutic options represent a new age for treatment of high-risk non–muscle invasive bladder cancer.